Lymphangitis secondary prevention: Difference between revisions
Created page with "__NOTOC__ {{Lymphangitis}} {{CMG}}; {{AE}} {{VR}} ==Overview== Lymphangitis is most often caused by recurrent skin infections due to Streptococcus pyogenes|group A beta-he..." |
Kiran Singh (talk | contribs) |
||
| Line 19: | Line 19: | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 19:47, 9 June 2015
|
Lymphangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphangitis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Lymphangitis secondary prevention |
|
Risk calculators and risk factors for Lymphangitis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2]
Overview
Lymphangitis is most often caused by recurrent skin infections due to group A beta-hemolytic streptococci and prophylactic administration of antibiotics can reduce the risk of these skin infections complicating into lymphangitis.
Secondary Prevention
Most of recurrent cellulitis is caused by group A beta-hemolytic streptococci, thus monthly administration of 1.2 MU of intramuscular benzathine penicillin or 250 mg of oral erythromycin or 1 g of penicillin V in adults can reduce the risk of development of lymphangitis.[1]
References
- ↑ Moran GJ, Abrahamian FM, Lovecchio F, Talan DA (2013). "Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines". J Emerg Med. 44 (6): e397–412. doi:10.1016/j.jemermed.2012.11.050. PMID 23466022.